On the other hand, insulin resistance induces dyslipidemia by affecting the low-density lipoprotein receptor (LDL) and consequently removing LDL, decreasing lipoprotein lipase (LPL) activity, and overactivating liver lipase (HL). Here, LPL is linked to metabolic syndrome.